8 completed. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow GLPG1205: new trials by email Literature Review of GLPG1205 trials Research Report on GLPG1205
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205 GLPG1205 film-coated tablets, [14C]-GLPG1205 solution for infusion, GLPG1205 capsules - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 12 | 2021-01-13 | 2021-03-25 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects GLPG1205, Placebo - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 32 | 2020-08-18 | 2020-12-22 |
| A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) GLPG1205, Placebo - Idiopathic Pulmonary Fibrosis | Phase 2 | Completed | Lakefront Biotherapeutics NV | 68 | 2018-09-27 | 2021-09-14 |
| This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects GLPG1205 50mg q.d., Placebo oral capsule, GLPG1205 250 loading dose and 50mg q.d. maintenance dose - Healthy, Elderly | Phase 1 | Completed | Lakefront Biotherapeutics NV | 32 | 2016-10-18 | 2017-04-05 |
| A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects GLPG1205, Placebo, Cocktail of CYP450 substrates - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 14 | 2015-10-01 | 2016-02-23 |
| Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis GLPG1205, Placebo - Ulcerative Colitis | Phase 2 | Completed | Lakefront Biotherapeutics NV | 64 | 2014-12-01 | 2015-11-20 |
| Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food 100 mg GLPG1205 - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 12 | 2014-05-01 | 2014-07-22 |
| First-in-Human Single and Multiple Dose of GLPG1205 GLPG1205 single ascending doses, oral suspension, Placebo single ascending doses, oral suspension, GLPG1205, multiple ascending doses, oral suspension - Healthy | Phase 1 | Completed | Lakefront Biotherapeutics NV | 40 | 2013-06-01 | 2013-10-16 |
Colitis, Ulcerative (1) · Idiopathic Pulmonary Fibrosis (1)
Lakefront Biotherapeutics NV (8)
Belgium (5) · Bulgaria (1) · Croatia (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Oman (1) · Poland (1) · Romania (1) · Russia (1) · Slovakia (1) · Sweden (1) · Ukraine (1)
Christian Seemayer, MD (1) · Ekaterina Tankisheva, MD (1) · Ekaterina Tankisheva, MD, PhD (1) · Helen Timis, MBChB MICR (1)
2014 (1), 2015 (1), 2017 (1)